News
(2)April 2026
ADCT proposes governance votes and capital structural changes at AGM
# 📜 What This Document Is 🗳️ This document is a Proxy Statement, which is a mandatory filing used to gather instructions from shareholders before an Annual General Meeting (AGM). Think of it as the owner's manual for the year, detailing what decisions the company needs you, the shareholder, to vot
ADCT Proposes Capital Range Increase for Future Flexibility
# 🧾 What This Document Is This is a **preliminary proxy statement** (PRE 14A) for ADC Therapeutics. Think of it as an invitation and information packet for the company's most important annual event: the **2026 Annual General Meeting of Shareholders**. It outlines everything shareholders need to kno
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.